325 related articles for article (PubMed ID: 16706571)
1. Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.
Kaper J; Wagena EJ; van Schayck CP; Severens JL
Pharmacoeconomics; 2006; 24(5):453-64. PubMed ID: 16706571
[TBL] [Abstract][Full Text] [Related]
2. Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial.
Kaper J; Wagena EJ; Willemsen MC; van Schayck CP
Addiction; 2005 Jul; 100(7):1012-20. PubMed ID: 15955017
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
Hoogendoorn M; Welsing P; Rutten-van Mölken MP
Curr Med Res Opin; 2008 Jan; 24(1):51-61. PubMed ID: 18021492
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students.
Popp J; Nyman JA; Luo X; Bengtson J; Lust K; An L; Ahluwalia JS; Thomas JL
Eur J Health Econ; 2018 Dec; 19(9):1319-1333. PubMed ID: 29687268
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness and cost-utility analysis of a work-place smoking cessation intervention with and without financial incentives.
van den Brand FA; Nagelhout GE; Winkens B; Chavannes NH; van Schayck OCP; Evers SMAA
Addiction; 2020 Mar; 115(3):534-545. PubMed ID: 31849138
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.
Cromwell J; Bartosch WJ; Fiore MC; Hasselblad V; Baker T
JAMA; 1997 Dec; 278(21):1759-66. PubMed ID: 9388153
[TBL] [Abstract][Full Text] [Related]
7. If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands.
Vemer P; Rutten-van Mölken MP; Kaper J; Hoogenveen RT; van Schayck CP; Feenstra TL
Addiction; 2010 Jun; 105(6):1088-97. PubMed ID: 20659063
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the cost-effectiveness of a high- and a low-intensity smoking cessation intervention in Sweden: a randomized trial.
Nohlert E; Helgason AR; Tillgren P; Tegelberg A; Johansson P
Nicotine Tob Res; 2013 Sep; 15(9):1519-27. PubMed ID: 23404735
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease.
Berndt N; Bolman C; Lechner L; Max W; Mudde A; de Vries H; Evers S
Eur J Health Econ; 2016 Apr; 17(3):269-85. PubMed ID: 25796578
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women: a randomized controlled trial.
Ruger JP; Weinstein MC; Hammond SK; Kearney MH; Emmons KM
Value Health; 2008; 11(2):191-8. PubMed ID: 17854434
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
[TBL] [Abstract][Full Text] [Related]
13. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence.
Kaper J; Wagena EJ; Willemsen MC; van Schayck CP
Addiction; 2006 Nov; 101(11):1656-61. PubMed ID: 17034446
[TBL] [Abstract][Full Text] [Related]
15. A model for cost-effectiveness analyses of smoking cessation interventions applied to a Quit-and-Win contest for mothers of small children.
Johansson PM; Tillgren PE; Guldbrandsson KA; Lindholm LA
Scand J Public Health; 2005; 33(5):343-52. PubMed ID: 16265801
[TBL] [Abstract][Full Text] [Related]
16. Tobacco control policies specified according to socioeconomic status: health disparities and cost-effectiveness.
Over EA; Feenstra TL; Hoogenveen RT; Droomers M; Uiters E; van Gelder BM
Nicotine Tob Res; 2014 Jun; 16(6):725-32. PubMed ID: 24388862
[TBL] [Abstract][Full Text] [Related]
17. The SmokingPaST Framework: illustrating the impact of quit attempts, quit methods, and new smokers on smoking prevalence, years of life saved, medical costs saved, programming costs, cost effectiveness, and return on investment.
O'Donnell MP; Roizen MF
Am J Health Promot; 2011; 26(1):e11-23. PubMed ID: 21879928
[TBL] [Abstract][Full Text] [Related]
18. The cost utility of bupropion in smoking cessation health programs: simulation model results for Sweden.
Bolin K; Lindgren B; Willers S
Chest; 2006 Mar; 129(3):651-60. PubMed ID: 16537864
[TBL] [Abstract][Full Text] [Related]
19. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
Bertram MY; Lim SS; Wallace AL; Vos T
Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
[TBL] [Abstract][Full Text] [Related]
20. The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop.
Guerriero C; Cairns J; Roberts I; Rodgers A; Whittaker R; Free C
Eur J Health Econ; 2013 Oct; 14(5):789-97. PubMed ID: 22961230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
